Monday, March 25, 2024 1:27:16 PM
Countering that argument, however, is the fact that they have hired a very reputable law firm with much experience in OTC matters ,and the OTC has recently changed CYBL's status to where they're now able to submit financial forms for review--something not available to them for many months now.
So, it's a more mixed bag than you present, although I'm certainly not holding my breath here, after 15 months of this farce, along with Rosen's truly pathetic track record here. And those Buffalo Fireside Chats are an absolute junior high school-like production, rarely yielding any accurate, helpful info on the company.
In conclusion, "It aint over till the fat lady sings" and while she's walking towards the mic, she aint there yet!!!
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM